Moreover, the predictive power of FBLIM1 expression was estimated by the ROC analysis, which unveiled that FBLIM1 expression could, respectively, forecast the 1-year (0.772), 3-year (0.788), and 5-year (0.729) survival of glioma patients (Figure 3d) in an effective way. The gene discussed is FBLIM1; the disease is glioma.